Clinical Trial Update: Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating dual-target CD70/CAIX CAR-NK cells for advanced or metastatic clear cell renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• CD70/CAIX CAR-NK cells

Snippet

Sponsor: Beijing Biotech | Conditions: Advanced or Metastatic Clear Cell Renal Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING